focus -WSS

focus

author：fashion 2025-10-02 21:36:13 - browse：675

Methadone and buprenorphine, both FDA-approved drugs, are considered the gold standard for treating opioid use disorder. They are so effective, in fact, that they are considered nearly curative for people who use them as prescribed. But a multitude of social and physical barriers to access mean that only about 20% of people who could benefit from these medicines have access to them. Access is even harder for pregnant people, who face additional stigmas and challenges.

Arthur Robin Williams, an addiction psychiatrist, and Judith Cole, a nurse practitioner, join the podcast this week to speak about the challenges during pregnancy, including the reality that federal law makes it possible for child protective services to be called when people receiving legal effective treatments for addiction give birth. Despite medications like methadone being fully safe during pregnancy, they continue to carry a stigma that can result in trauma for both birth parents and newborns.

“What’s getting conflated here is a result on a drug test, for instance, with actual abuse or neglect,” said Williams.

Williams and Cole wrote about this issue in their recent First Opinion essay, “Mothers in treatment for opioid use disorder shouldn’t also have to fight child protective services.” You can read more about barriers to addiction treatment in STAT reporter Lev Facher’s series “The War on Recovery.”

Be sure to sign up for the weekly “First Opinion Podcast” on Apple Podcasts, Spotify, Google Play, or wherever you get your podcasts. And don’t forget to sign up for the First Opinion newsletter to read each week’s best First Opinion essays.

Previous article： Virginia high school admissions case could be legal follow
Next article： Information blocking fines are now fair game in health care

explore

WSS

Why the quest to eradicate polio has stumbled

Chronically ill young patients struggle to find fertility info

JPM 2024 Day 3: Biotech Updates from Verve, Roivant, etc

The biotech scorecard for Q1: 17 stock

Readout Newsletter: Allogene's pivot, Illumina exec to lead Delfi

Goldman Sachs launches $650M fund for life science investments

hotspot

focus

focus

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

JPM 2024 Day 3: Biotech Updates from Verve, Roivant, etc

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

'A game

Continuity nursing helped my family in our darkest PICU moments

The unintended consequences of overturning Roe v. Wade

Dobbs anniversary: the lost opportunity of abortion as health care

Grad students accuse University of California of wage theft

Medicare details structure of new drug price negotiation program

Burning questions for the 2024 JPM Healthcare Conference

knowledge

Susan Tousi leaves Illumina to head cancer liquid biopsy startup

Feng Zhang, Grail founder join forces on new gene editing startup

Akili changes sales model for its ADHD video game treatment

Goldman Sachs launches $650M fund for life science investments

The FDA must approve intranasal treatments for anaphylaxis

The struggle to figure out which patients 'deserve' Wegovy

explore

explore

entertainment

focus